Tim A. D. Smith
John Mallard PET Centre
School of Medical Sciences
University of Aberdeen
Foresterhill
Scotland
Name/email consistency: high
- Treatment of breast tumor cells in vitro with the mitochondrial membrane potential dissipater valinomycin increases 18F-FDG incorporation. Smith, T.A., Blaylock, M.G. J. Nucl. Med. (2007)
- Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro. Smith, T.A., Sharma, R.I., Wang, W.G., Welch, A.E., Schweiger, L.F., Collie-Duguid, E.S. Nucl. Med. Biol. (2007)
- Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro. Smith, T.A., Sharma, R.I., Thompson, A.M., Paulin, F.E. J. Nucl. Med. (2006)
- [methyl-3H]Choline incorporation into MCF7 tumour cells: correlation with proliferation. Al-Saeedi, F., Welch, A.E., Smith, T.A. Eur. J. Nucl. Med. Mol. Imaging (2005)
- Human serum transferrin cobalt complex: stability and cellular uptake of cobalt. Smith, T.A. Bioorg. Med. Chem. (2005)
- 99mTc-labelled human serum transferrin for tumour imaging: an in vitro and in vivo study of the complex. Smith, T.A., Perkins, A.C., Walton, P.H. Nucl. Med. Commun (2004)